Sean Maduck resigned as President of Corcept Endocrinology effective October 1, 2026, and will serve as a senior commercial advisor under a consulting agreement paying $57,000 per month through September 30, 2027. Justin Gunn succeeds Mr. Maduck in the role, reporting to CEO Joseph K. Belanoff. This leadership transition is not material to investor value.
